QQ客服 官方微博 反馈留言

	Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability
	Yin Juntao[1]; Xiang Cuiyu[2]; Song Xiaoyong[3]
刊名	INTERNATIONAL JOURNAL OF PHARMACEUTICS
	2016
卷号	510期号:1页码:203-209
关键词	Psoralidin Nanoencapsulation Eudragit S100 Chitosan Bioavailability Permeability
ISSN号	0378-5173
DOI	http://dx.doi.org/10.1016/j.ijpharm.2016.05.007
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000380754300020
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5204010
专题	河南大学
作者单位	1.[1]Department of Pharmaceutics, Huaihe Hospital Affiliated with Henan University, No. 1 Baobei Road, Kaifeng 475000, PR China. 2.[2]Department of Pharmaceutics, Huaihe Hospital Affiliated with Henan University, No. 1 Baobei Road, Kaifeng 475000, PR China. 3.[3]Department of Pharmaceutics, Huaihe Hospital Affiliated with Henan University, No. 1 Baobei Road, Kaifeng 475000, PR China. Electronic address: sxyyjk@sina.com.
推荐引用方式 GB/T 7714	Yin Juntao[1],Xiang Cuiyu[2],Song Xiaoyong[3]. Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS,2016,510(1):203-209.
APA	Yin Juntao[1],Xiang Cuiyu[2],&Song Xiaoyong[3].(2016).Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability.INTERNATIONAL JOURNAL OF PHARMACEUTICS,510(1),203-209.
MLA	Yin Juntao[1],et al."Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability".INTERNATIONAL JOURNAL OF PHARMACEUTICS 510.1(2016):203-209.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。